Sy Mukherjee

Sy Mukherjee is a former health care reporter for Fortune.

Page 56 of 100

  • Suicide attempts are on the rise.Health

    Suicide Became the Second Leading Cause of Death for Young People in 2016. We Don’t Know Why

    By
  • Doctor in white lab coat grips stethoscopeHealth

    An All-Star Panel Tackles Trump’s Drug Price Plan, Innovation in Health Care—And More

    By
  • Argentina v Chile: Group D - Copa America CentenarioHealth

    STD Cases Just Reached a Record High in California. Here’s What You Need to Know

    By
  • Health

    Brainstorm Health: All-Star Health Care Panel, California STD Cases, New CRISPR Company

    By
  • Johnson And Johnson Recalls Children's Cold MedicinesHealth

    We Don’t Have a Cure for the Common Cold. But This New Treatment Might Stop It in Its Tracks

    By
  • Health

    Brainstorm Health: Common Cold Drug, WHO and Trans Fat, Azar and Drug Pricing

    By
  • President Trump Delivers Remarks On Lowering Drug Prices In Rose GardenHealth

    Why Trump’s Big Drug Price Speech Sent Health Care Stocks Soaring

    By
  • Health

    Brainstorm Health: Trump Drug Price Speech, Ebola Outbreak, Novartis’ Bad Day

    By
  • Health

    Instead of Giving Her a Prosthetic Ear, Army Doctors Grew a New One in This Soldier’s Arm

    By
  • Health

    Brainstorm Health: Growing an Ear in an Arm, Pot and Pregnant Women, Health App Effectiveness

    By
  • US-POLITICS-INVESTIGATION-TRUMP-courtHealth

    That $1.2 Million Payment to Trump’s Lawyer Wasn’t Even a Drop in the Bucket for Novartis

    By
  • Global Pharmaceuticals BrandsHealth

    What You Need to Know About the EpiPen Shortage the FDA Just Declared

    By
  • Drug counsellor testing urine for traces of drugs.Health

    Far More U.S. Workers Had Positive Drug Tests for Cocaine, Meth, and Marijuana in 2017 Than the Year Before

    By
  • Health

    Brainstorm Health: Takeda Scores Shire, Valeant Name Change, Walmart Opioids Plan

    By
  • Valeant Pharmaceuticals Offices Ahead Of Earnings FiguresHealth

    Valeant Is Changing Names—And Its Stock Is Soaring After a Much-Needed FDA Approval

    By